Faisal Khurshid
Stock Analyst at Jefferies
(4.96)
# 96
Out of 4,429 analysts
233
Total ratings
61.4%
Success rate
69.4%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Downgraded: Hold | $160 → $90 | $99.15 | -9.23% | 3 | Jun 1, 2026 | |
| PTCT PTC Therapeutics | Upgraded: Buy | $76 → $85 | $78.98 | +7.62% | 2 | May 27, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $17 | $13.75 | +23.64% | 3 | May 21, 2026 | |
| ONC BeOne Medicines AG | Maintained: Hold | $290 → $333 | $270.15 | +23.26% | 2 | May 21, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $290 | $230.83 | +25.63% | 2 | May 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $40 → $37 | $19.00 | +94.74% | 2 | May 1, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $140 | $162.99 | -14.11% | 2 | Apr 10, 2026 | |
| VSTM Verastem | Initiated Coverage: Buy | $15 | $4.12 | +264.08% | 1 | Mar 30, 2026 | |
| VRDN Viridian Therapeutics | Rated: Buy | $29 | $16.63 | +74.38% | 1 | Mar 30, 2026 | |
| FDMT 4D Molecular Therapeutics | Initiated Coverage: Buy | $21 | $9.66 | +117.39% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $120 | $79.49 | +50.96% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $228 | $95.80 | +138.00% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $34.54 | +59.24% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 | $278.09 | +18.67% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $98.22 | -4.30% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $9.78 | +84.05% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $90.43 | +21.64% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $28.60 | +15.38% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $12.44 | +20.58% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $96.79 | +46.71% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $11.94 | +75.88% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $5.53 | -27.67% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $17.55 | -31.62% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $28.32 | +41.24% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.94 | +128.43% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4505 | - | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.34 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.75 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.21 | - | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.20 | - | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $112.86 | - | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $88.34 | - | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $4.95 | -59.60% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.26 | +138.10% | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $3.54 | -71.75% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.16 | +72.41% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.14 | - | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $2.06 | n/a | 7 | Nov 9, 2023 |
ABIVAX Société Anonyme
Jun 1, 2026
Downgraded: Hold
Price Target: $160 → $90
Current: $99.15
Upside: -9.23%
PTC Therapeutics
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $78.98
Upside: +7.62%
Summit Therapeutics
May 21, 2026
Maintained: Hold
Price Target: $17
Current: $13.75
Upside: +23.64%
BeOne Medicines AG
May 21, 2026
Maintained: Hold
Price Target: $290 → $333
Current: $270.15
Upside: +23.26%
Ascendis Pharma
May 6, 2026
Maintained: Buy
Price Target: $290
Current: $230.83
Upside: +25.63%
Syndax Pharmaceuticals
May 1, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $19.00
Upside: +94.74%
Revolution Medicines
Apr 10, 2026
Maintained: Buy
Price Target: $140
Current: $162.99
Upside: -14.11%
Verastem
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
Viridian Therapeutics
Mar 30, 2026
Rated: Buy
Price Target: $29
Current: $16.63
Upside: +74.38%
4D Molecular Therapeutics
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $9.66
Upside: +117.39%
Mar 25, 2026
Maintained: Buy
Price Target: $103 → $120
Current: $79.49
Upside: +50.96%
Mar 17, 2026
Reiterated: Buy
Price Target: $228
Current: $95.80
Upside: +138.00%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $34.54
Upside: +59.24%
Mar 15, 2026
Downgraded: Hold
Price Target: $330
Current: $278.09
Upside: +18.67%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $98.22
Upside: -4.30%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $9.78
Upside: +84.05%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $90.43
Upside: +21.64%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $28.60
Upside: +15.38%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $12.44
Upside: +20.58%
Dec 15, 2025
Maintained: Buy
Price Target: $142
Current: $96.79
Upside: +46.71%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $11.94
Upside: +75.88%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $5.53
Upside: -27.67%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $17.55
Upside: -31.62%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $28.32
Upside: +41.24%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.94
Upside: +128.43%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.4505
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.34
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.75
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.21
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.20
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $112.86
Upside: -
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $88.34
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $4 → $2
Current: $4.95
Upside: -59.60%
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.26
Upside: +138.10%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $3.54
Upside: -71.75%
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.16
Upside: +72.41%
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $74.14
Upside: -
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $2.06
Upside: n/a